Aberrant expression of miR-133a in endothelial cells inhibits angiogenesis by reducing pro-angiogenic but increasing anti-angiogenic gene expression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aberrant expression of miR-133a in endothelial cells inhibits angiogenesis by reducing pro-angiogenic but increasing anti-angiogenic gene expression ; volume:12 ; number:1 ; day:30 ; month:8 ; year:2022 ; pages:1-15 ; date:12.2022
Scientific reports ; 12, Heft 1 (30.8.2022), 1-15, 12.2022
- Urheber
-
Ahmed, Suhail
Kurusamy, Sathishkumar
David, Ezra Leander Santhosh
Khan, Kinza
Kalyanakrishnan, Krithika
Ian-Gobo, Miebaka
Kola, Teja Manidhar
Wilkinson, Robert N.
Kannappan, Vinodh
Wang, Weiguang
Gómez, Manuel J.
Redondo, Juan Miguel
Cotton, James
Armesilla, Angel L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-19172-x
- URN
-
urn:nbn:de:101:1-2022111721073251442778
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ahmed, Suhail
- Kurusamy, Sathishkumar
- David, Ezra Leander Santhosh
- Khan, Kinza
- Kalyanakrishnan, Krithika
- Ian-Gobo, Miebaka
- Kola, Teja Manidhar
- Wilkinson, Robert N.
- Kannappan, Vinodh
- Wang, Weiguang
- Gómez, Manuel J.
- Redondo, Juan Miguel
- Cotton, James
- Armesilla, Angel L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic alternatives to VEGF blockade
Anti-angiogenic therapies in brain metastases
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Enhancing the anti-angiogenic action of histone deacetylase inhibitors